Fed. Circ. Affirms Histogen Win In Skin Care IP Suit

Law360, New York (August 23, 2013, 10:16 PM ET) -- The Federal Circuit on Friday refused to revive an infringement suit that the skin care company SkinMedica Inc. filed against rival Histogen Inc. over its ReGenica skin repair products, upholding a lower court's finding the patents did not cover the accused infringer’s skin cell growth process.

In a precedential split decision, the three-judge panel backed the trial court's interpretation of the patents' wording, agreeing that SkinMedica described its method for developing skin cells as different than, and superior to, the method used by the company it...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required